Insider Trading News

Robert J. Ben, CFO of Richardson Electronics, LTD. (NASDAQ:RELL), sold 9,500 shares of common stock on October 14, 2025, in two separate transactions. The sales were executed at...

Saba Capital Management, L.P., a ten-percent owner of BlackRock ESG Capital Allocation Term Trust (NYSE:ECAT), sold 57,169 shares of common stock in two transactions, generating...

Saba Capital Management, L.P., a ten-percent owner of ASA Gold & Precious Metals Ltd (NYSE:ASA), has recently increased its stake in the company. According to a Form 4 filing with...

Following these transactions, Santana directly owns 131,335 shares of Westinghouse Air Brake Technologies CORP. The company has demonstrated consistent performance, with...

Director Gregg Williams of Vivani Medical (NASDAQ:VANI), a company currently valued at $78.2 million, recently purchased a total of 1,737,764 shares of common stock in two separate...

Jane Chung, Chief Executive Officer of Sutro Biopharma, Inc. (NASDAQ:STRO), acquired 12,500 shares of common stock on October 15, 2025, at a price of $0.8009 per share, in a...

Hans-Peter Gerber, Chief Scientific Officer at Sutro Biopharma Inc (NASDAQ:STRO), purchased 17,000 shares of common stock on October 15, 2025, according to a Form 4 filing with the...

CFO Chow Gregory K. of Sutro Biopharma Inc (NASDAQ:STRO) acquired 19,750 shares of common stock on October 15, 2025, according to a Form 4 filing with the Securities and Exchange...

Director Connie Matsui of Sutro Biopharma (NASDAQ:STRO) acquired 50,000 shares of common stock on October 15, 2025, at a price of $0.799 per share. The total value of the purchase...

David Pauling, Chief Administrative Officer & General Counsel at Sutro Biopharma Inc (NASDAQ:STRO), recently purchased 12504 shares of the company’s common stock. The...

Y.D. More Investments Ltd, a ten percent owner of Odysight.ai Inc (NASDAQ:ODYS), sold 900 shares of common stock at $3.44 on October 15, 2025, according to a Form 4 filing with the...

Vistra Corp (NYSE:VST) CEO James A. Burke sold a total of $17.2 million in common stock between October 10 and October 14, 2025. The sales occurred at prices ranging from $201.12...

Cooperatieve Gilde Healthcare IV U.A., a ten percent owner of LAVA Therapeutics NV (NASDAQ:LVTX), has sold 474,927 common shares of the company for approximately $718,721. The...

Director John L. Hennessy of Alphabet Inc (NASDAQ:GOOGL) sold a total of $145,754 worth of Class C Capital Stock on October 13, 2025. The sales occurred in multiple transactions...

Verisk Analytics Inc (NASDAQ:VRSK) Chief Financial Officer Elizabeth Mann sold 300 shares of common stock on October 15, 2025, for $242.23, totaling $72,669. The transaction comes...

Magnetar Financial LLC, along with Magnetar Capital Partners LP, Supernova Management LLC, and David J. Snyderman, reported selling shares of CoreWeave, Inc. NASDAQ:CRWV on October...

Director Dunlop A. Sinclair of Apellis Pharmaceuticals Inc (NASDAQ:APLS), a biotech company with a market capitalization of $3.17 billion, recently sold 31,092 shares of common...

Decheng Capital, a major shareholder in BeyondSpring Inc. (NASDAQ:BYSI), has sold a total of 153,816 shares of the company’s ordinary shares between October 13 and October...

Magnetar Financial LLC, along with Magnetar Capital Partners LP, Supernova Management LLC, and David J. Snyderman, reported selling shares of CoreWeave, Inc. NASDAQ:CRWV on October...

Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC, and Snyderman David J., all identified as ten percent owners of CoreWeave, Inc. (CRWV), reported...

Arcellx, Inc. (NASDAQ:ACLX) Chief Financial Officer Michelle Gilson sold 5,364 shares of the company’s common stock on October 15, 2025, for approximately $488,315. The...

Winvest Investment Fund Management Corp., a ten percent owner of Bollinger Innovations, INC. (BINI), sold 29,589 shares of common stock on October 10, 2025, for approximately...

Director Lu James Fu Bin, a ten percent owner of Grindr Inc. (NYSE:GRND), a $2.39 billion market cap company, recently sold 649,900 shares of common stock in three separate...

Adam Scott Levy, Chief Financial Officer and Secretary of Mineralys Therapeutics Inc (NASDAQ:MLYS), sold a total of 10,758 shares of common stock on October 13, 2025, for...

Chief Medical Officer of Mineralys Therapeutics (NASDAQ:MLYS), David Malcom Rodman, sold 10,369 shares of common stock on October 15, 2025, according to a Form 4 filing with the...

Jon Congleton, Chief Executive Officer of Mineralys Therapeutics, Inc. (NASDAQ:MLYS), sold a total of 15,100 shares of common stock on October 13, 2025, according to a Form 4...

Life360, Inc. (OTCQX:LIF) Director Charles J. Prober sold 7,930 shares of common stock on October 13, 2025, for $103.20, totaling $818,376. On the same day, Prober exercised...

Alkermes (NASDAQ:ALKS), a $5.3 billion biopharmaceutical company with a "GREAT" financial health rating according to InvestingPro, saw its Executive Vice President of Research and...

Director Daniel N. Swisher JR, of Corcept Therapeutics Inc (NASDAQ:CORT), sold 2,200 shares of common stock on October 10, 2025, at a price of $87.54, for a total value of...

Director Booth indirectly sells Sionna Therapeutics (NASDAQ:SION) shares worth approximately $5.9 million between October 10 and October 15. The sales, executed under 10b5-1...

Reprogrammed Interchange LLC and Reid Hoffman, both listed as 10% owners of Vor Biopharma Inc (NASDAQ:VOR), have collectively sold 65,357 shares of common stock for approximately...

Brad Brubaker, General Counsel and Chief Legal Officer at UiPath (NYSE:PATH), sold 27,580 shares of Class A Common Stock on October 15, 2025. The transactions were executed at a...

Chief Accounting Officer of UiPath (NYSE:PATH), Hitesh Ramani, sold 20,000 shares of Class A Common Stock in two transactions on October 14 and 15, 2025, for a total value of...

UiPath, Inc. (NYSE:PATH), a robotic process automation company with an $8.84 billion market cap and impressive 83% gross profit margins, saw CEO and Chairman Daniel Dines sell...

Claire Mazumdar, Chief Executive Officer of Bicara Therapeutics Inc (NASDAQ:BCAX), sold 24,734 shares of common stock for approximately $466,936, according to a Form 4 filing with...